These results indicate that p53 loss in HCC alters the expression of major iron metabolic genes, which is potentially associated with increased iron uptake and utilization by p53-deficient cancer cells, required to sustain their high proliferative capacity and development into an aggressive phenotype. The gene discussed is TP53; the disease is cancer.